Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 174,739 | 191,014 | 235,869 | 296,188 | 348,983 |
Cost of Goods | 47,447 | 49,646 | 58,492 | 85,473 | 102,593 |
Gross Profit | 127,292 | 141,368 | 177,377 | 210,715 | 246,390 |
Operating Expenses | 119,799 | 133,338 | 152,360 | 172,482 | 193,472 |
Operating Income | 7,940 | 8,676 | 25,509 | 38,706 | 53,511 |
Other Income | 3,645 | 1,126 | 1,040 | 411 | -182 |
Pre-tax Income | 11,585 | 9,802 | 26,549 | 39,117 | 53,329 |
Income Tax | 3,269 | 3,766 | 3,418 | 8,837 | 13,361 |
Net Income Continuous | 8,316 | 6,036 | 23,131 | 30,280 | 39,968 |
Net Income | $8,316 | $6,036 | $23,131 | $30,280 | $39,968 |
EPS Basic Total Ops | 0.76 | 0.55 | 2.12 | 2.78 | 3.68 |
EPS Basic Continuous Ops | 0.76 | 0.55 | 2.12 | 2.78 | 3.68 |
EPS Diluted Total Ops | 0.76 | 0.54 | 2.12 | 2.77 | 3.67 |
EPS Diluted Continuous Ops | 0.76 | 0.55 | 2.12 | 2.77 | 3.67 |
EPS Diluted Before Non-Recurring Items | N/A | 1.09 | 2.12 | 2.77 | 3.67 |
EBITDA(a) | $11,010 | $11,860 | $28,921 | $42,074 | $56,485 |